xolair
novartis europharm limited - omalizumab - asthma; urticaria - preparaty do obturacyjne choroby dróg oddechowych, - alergiczne asthmaxolair jest wskazany u dorosłych, młodzieży i dzieci (od 6 do.
columvi
roche registration gmbh - glofitamab - lymphoma, large b-cell, diffuse - Środki przeciwnowotworowe - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.
tepkinly
abbvie deutschland gmbh & co. kg - epcoritamab - lymphoma, large b-cell, diffuse - Środki przeciwnowotworowe - tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) after two or more lines of systemic therapy.
lunsumio
roche registration gmbh - mosunetuzumab - chłoniak, mieszek włosowy - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.
kimmtrak
immunocore ireland limited - tebentafusp - uveal neoplasms - Środki przeciwnowotworowe - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.
doloxib 30 mg tabletki powlekane
zentiva, k.s. - etoricoxibum - tabletki powlekane - 30 mg
doloxib 60 mg tabletki powlekane
zentiva, k.s. - etoricoxibum - tabletki powlekane - 60 mg
doloxib 90 mg tabletki powlekane
zentiva, k.s. - etoricoxibum - tabletki powlekane - 90 mg
doloxib 120 mg tabletki powlekane
zentiva, k.s. - etoricoxibum - tabletki powlekane - 120 mg